La chaîne d'options affiche les données clés des options sur actions de NewAmsterdam Pharma à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour NewAmsterdam Pharma..

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Chaîne d'Options

NewAmsterdam Pharma

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co NV

NewAmsterdam Pharma Company N.V. - Warrant

NamSys Inc

Shares of Alibaba Group Holding Ltd ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) declined on Monday and the Chinese technology giant's Hong Kong-listed shares continued to fall on Tuesday triggered by President Donald Trump's remarks to limit Chinese spending and investment.
What Happened: Jack Ma&#8217;s BABA which has gained 51.90% on a year-to-date basis and its HK counterpart 9988 which was up 60.39% during the same period fell after Trump's memo directed the Committee on Foreign Investment to take action.
The committee is a secretive panel that reviews foreign investments in companies or property for potential national security risks.
As reported <a href="https://www.bloomberg.com/news/articles/2025-02-24/trump-targets-china-with-biggest-salvo-of-moves-of-second-term">by</a> Bloomberg, the panel was asked by the President to curb <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43924817/chinese-stocks-are-on-the-rise-today-whats-going-on">Chinese</a> spending on technology and other strategic U.S. sectors. Furthermore, to counter China&#8217;s dominance in shipbuilding, the U.S. proposed fees for the use of Chinese-made commercial ships.
See Also: <a href="https://www.benzinga.com/25/02/43932776/mark-cuban-slams-fd-up-healthcare-system-blames-insurance-designed-deductibles-for-patient-bankruptcy">Mark Cuban Calls Deductibles &#8216;The Biggest Problem&#8217; in Healthcare: &#8216;System…Needs To Be Redesigned&#8217;</a>
Why It Matters: Alibaba's U.S.-listed American depository receipts have rallied 43.39% since the Jan. 25 weekend, when DeepSeek topped Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) App Store charts and Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) fell 17%.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025732/BABA-since-DeepSeek-1024x576.png" alt="" class="wp-image-796866" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025732/BABA-since-DeepSeek-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025732/BABA-since-DeepSeek-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025732/BABA-since-DeepSeek-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025732/BABA-since-DeepSeek-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025732/BABA-since-DeepSeek.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
However, BABA sank 10.23% to $129.04 apiece on Monday and 9988 was trading 4.05% lower as of the publication of this article.
Meanwhile, <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data indicated that the stock was still above its eight-day and 20-day average in the short term. Additionally, it was above the longer-term 50-day and 200-day averages displaying bullish trends.
Momentum indicators were also strong. The relative strength index fell below the overbought to neutral zone at 66.86 while it still had a positive MACD of 11.65, indicating the possibility of a further positive move.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025630/BABA-Technical-chart-1024x576.png" alt="" class="wp-image-796864" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025630/BABA-Technical-chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025630/BABA-Technical-chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025630/BABA-Technical-chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025630/BABA-Technical-chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025630/BABA-Technical-chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<a href="https://www.benzinga.com/quote/BABA/analyst-ratings">Benzinga tracks 21 analysts</a> with an average price target of $135.1 for the stock, reflecting a &#8220;buy&#8221; rating. Estimates range widely from $85 to $190. Recent ratings from Morgan Stanley, Benchmark, and JP Morgan average $180, suggesting a potential 40.31% upside.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="387" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025613/BABA-ANR-latest-1024x387.png" alt="" class="wp-image-796863" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025613/BABA-ANR-latest-1024x387.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025613/BABA-ANR-latest-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025613/BABA-ANR-latest-768x290.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25025613/BABA-ANR-latest.png 1066w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43906366/warren-buffetts-berkshire-boosts-bets-on-five-japanese-companies-admiration-has-consistently-grown-says-oracle-of-omaha-in-letter-to-shareholders" target="_blank" rel="noreferrer noopener">Warren Buffett's Berkshire Boosts Bets On 5 Japanese Companies: Oracle Of Omaha Says Admiration ‘Has Consistently Grown'</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

News

Markets

Analyst Ratings

BABA

NVDA

Alibaba Sinks 4% In Hong Kong After US-Listed ADRs Plunge 10% As Trump Limits Foreign Investments In Chinese Tech

The CEO of&nbsp;Nike Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), Elliott Hill, has earned the confidence of Jeffries analyst Randal Konik, who is optimistic about Hill&#8217;s strategic plans for the company.
What Happened: Konik, in his analyst note to clients, shared that Hill&#8217;s strategy to rejuvenate wholesale partnerships and launch new products will substantially enhance Nike&#8217;s profitability and market share in the athletic footwear industry in the foreseeable future, <a href="https://www.marketwatch.com/story/buy-nikes-stock-aggressively-as-new-ceos-playbook-should-work-analyst-says-6981a18a">reported</a> Market Watch. As a result, Konik upgraded his rating on Nike&#8217;s stock from &#8216;Hold&#8217; to &#8216;Buy&#8217;, dubbing it his &#8220;new top pick.&#8221;
Konik also raised his stock price target for Nike to $115 from $75, suggesting a potential 43.2% upside from the closing price of $80.28 on Monday. He opines that the current valuation of Nike&#8217;s stock, regarding sales expectations for the upcoming year, is at its lowest in ten years, creating a &#8220;valuation floor.&#8221;
"With shares near a valuation trough, we believe now is the right time to aggressively buy shares," wrote Konik in the note.
Despite past missteps, including a reduced focus on product innovation and an excessive emphasis on Nike Digital and direct sales, Konik remains confident that Hill&#8217;s expertise and strategy will resolve these challenges. He also pointed out a notable rise in job postings for product roles, indicating a renewed focus on product innovation.
Konik anticipates a V-shaped recovery in margins by 2027, pushing earnings above current Wall Street expectations. A Jefferies survey found that more than half of U.S. consumers planning to purchase athletic footwear prefer Nike, reinforcing Konik&#8217;s optimistic outlook.
SEE ALSO:<a href="https://www.benzinga.com/25/02/43920072/taiwan-semiconductor-poised-for-surge-goldman-sachs-predicts-rising-demand-for-taipei-traded-shares"> Taiwan Semiconductor Poised For Surge, Goldman Sachs Predicts Rising Demand For Taipei-Traded Stock: Report</a>
Why It Matters: Nike&#8217;s strategic moves under Hill&#8217;s leadership have already begun to bear fruit. The company recently announced <a href="https://www.benzinga.com/25/02/43789704/kim-kardashians-skims-joins-forces-with-nike-to-redefine-fitness-fashion-stock-gains">the launch of NikeSKIMS</a>, a new brand developed in collaboration with SKIMS, an American shapewear and clothing brand co-founded by Kim Kardashian. 
Nike also returned to the Super Bowl advertisement arena after 27 long years. The brand hogged the limelight with its commercial putting a female athlete on centerstage. This ad aired at a time for Nike when it strives to revitalize its business following three consecutive quarters of declining revenue. In the quarter ending November, net revenue dropped 7.7% to $12.35 billion. The stock has plunged more than 23% over the last year.
The brand has been suffering since the COVID-19 pandemic after it spoiled relations with wholesalers in a bid to push direct-to-customer sales. However, investor confidence seems to have returned after the veteran CEO presented a turnaround plan in December.
Notably, Bill Ackman&#8216;s Pershing Square Holdings converted their <a href="https://in.benzinga.com/news/earnings/25/02/43756694/bill-ackmans-pershing-square-adjusts-portfolio-trims-chipotle-and-boosts-nike">Nike equity position</a> into deep-in-the-money call options in early 2025 sensing a potential upside to the stock. In their investor presentation, Pershing Square stated, &#8220;Hill is the ideal person to return Nike to dominance and growth.&#8221;
Nike stock jumped 4.9% yesterday following the bullish note by the Jeffries analyst.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/25/02/43933016/jamie-dimon-slams-inefficient-us-government-backs-elon-musks-doge-initiative">Jamie Dimon Slams &#8216;Inefficient&#8217; US Government, Backs Elon Musk&#8217;s DOGE Initiative</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Nike Shares Set For A Turnaround? Top Analyst Calls For 'Aggressive Buy' Amid New CEO's Turnaround Plan

General

Zscaler Launches To Advance How Organizations Manage Their Asset Risk

ChipMOS TECHNOLOGIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMOS#NASDAQ">IMOS</a>) reported quarterly earnings of $0.19 per share. This is a 55.81 percent decrease over earnings of $0.43 per share from the same period last year. The company reported $164.70 million in sales this quarter. This is a 11.93 percent decrease over sales of $187.00 million the same period last year.

Earnings

IMOS

ChipMOS TECHNOLOGIES Q4 EPS $0.19 Down From $0.43 YoY, Sales $164.70M Down From $187.00M YoY

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects The Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) to report quarterly earnings at $3.04 per share on revenue of $39.07 billion before the opening bell. Home Depot shares fell 1.2% to $378.00 in after-hours trading.</li>
<li>Analysts are expecting Keurig Dr Pepper Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) to post quarterly earnings at 57 cents per share on revenue of $4 billion. The company will release earnings before the markets open. Keurig Dr Pepper shares gained 0.4% to $34.27 in after-hours trading.</li>
<li>Trip.com Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) posted upbeat results for its fourth quarter on Monday. Trip.com Group shares gained 0.4% to $64.89 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>After the markets close, Workday Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) is projected to report quarterly earnings at $1.78 per share on revenue of $2.18 billion. Workday shares gained 0.4% to $262.89 in after-hours trading.</li>
<li>Analysts expect Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) to post quarterly earnings at $2.58 per share on revenue of $3.83 billion after the closing bell. Intuit shares gained 0.6% to $570.80 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43909562/top-2-industrials-stocks-that-are-set-to-fly-this-quarter">Top 2 Industrials Stocks That Are Set To Fly This Quarter</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

Trading Ideas

INTU

TCOM

WDAY

Home Depot, Keurig Dr Pepper And 3 Stocks To Watch Heading Into Tuesday

AHCO

ALLT

ARQT

AXGN

AXON

BASE

BGFV

BLZE

BTDR

BWIN

CART

CAVA

CBLL

CCCS

CECO

CGBD

CHRD

CIFR

CPNG

CPSS

DAWN

DNUT

DOCN

DRVN

ELAN

EXLS

FIHL

FLYW

FSLR

FULC

GPOR

HRMY

HSIC

HURN

HYLN

IART

ICCC

IGIC

INGN

INVX

IPAR

ITRI

IVAC

JACK

JAZZ

KEYS

KNSA

LCID

LGIH

LIVN

LMND

LXFR

MASI

MATX

MFIC

MIDD

MMSI

MPLN

MRVI

NOVT

NXRT

Earnings Scheduled For February 25, 2025

Tech

LDOS

Leidos Partners With AI Company SeeTrue To Improve The Efficiency Of Airport Security And Customs Screenings

Swedish EV maker Polestar Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) is offering up to $20,000 to Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) vehicle owners who choose to make a switch and lease a Polestar 3.
What Happened: &#8220;Make the switch to Polestar. Save up to $20,000 on a Polestar 3 lease as a Tesla owner,&#8221; the company says on its U.S. website.
The offer, which began on Feb. 21, expires on Feb 28. It is only available on the lease of a new model year 2025 Polestar 3 vehicle.
Polestar 3 is an SUV that starts at $67,500, cheaper than a Tesla Model X but pricier than the top variant of its Model Y. The long-range all-wheel drive variant of Tesla&#8217;s refreshed Model Y starts at $59,990.
Why It Matters: Polestar targeting Tesla owners is not unexpected. Polestar CEO Michael Lohscheller&nbsp;<a href="https://www.benzinga.com/tech/25/01/43155064/polestar-ceo-looks-to-attract-tesla-customers-disenchanted-by-elon-musks-politics-somebody-outside-of-germany-endorsing-right-wing-politicial-parties-totally-unacceptable">said in an interview last month</a> that Tesla CEO Elon Musk&#8216;s involvement in global politics is pushing away customers.
Lohscheller said that a lot of people have "very, very negative sentiment" about Musk's involvement in politics. The Polestar CEO also said that he has told the company's salespersons to target disappointed Tesla owners for potential business.
Lohscheller became CEO of Polestar in October. &#8220;Both in terms of volumes and financials, we expect 2025 to be the strongest year in Polestar&#8217;s history," the CEO said in January. 
The company reported a 15% drop in sales<a href="https://www.benzinga.com/markets/equities/25/01/42896581/polestar-sees-5-3-increase-in-q4-retail-sales-order-intake-surges-37-2" target="_blank" rel="noreferrer noopener">&nbsp;to 44,851 cars for the full year 2024.</a> 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43909679/tesla-cybercab-will-have-no-stainless-steel-panels-and-will-not-be-painted-either-says-senior-company-exec" target="_blank" rel="noreferrer noopener">Tesla's Cybercab To Ditch Stainless Steel And Paint, Says Senior Company Exec: Here's How It Will Get Its Signature Gold Look</a></li>
</ul>
Photo courtesy: Polestar

PSNY

TSLA

Polestar Attempts To Woo Disgruntled Tesla Owners With Offers: '2025 To Be Strongest Year In Polestar's History'

Teledyne e2v Launches High-Speed CMOS Image Sensor Lince5M NIR

Editor&#8217;s Note: This story has been updated to correct the 52-week high and low figures for Palantir and Berkshire Hathaway.
The stock market experienced a correction on Monday, with the Nasdaq Composite sliding over 200 points. Meanwhile, the Dow inched up 0.08% to 43,461.21, while the Nasdaq dropped 1.2% to 19,286.92. The S&amp;P 500 also declined, slipping 0.5% to 5,983.25.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Palantir Technologies Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)
Palantir shares fell by 10.53% to close at $90.68, with an intraday high and low of $99.01 and $89.3, respectively. The 52-week high and low stand at $125.41 and $20.33. The <a href="https://www.benzinga.com/general/market-summary/25/02/43920295/palantir-extends-losses-microsoft-slides-whats-driving-markets-monday">company&#8217;s shares extended losses</a> as the major indices struggled to maintain early momentum.
Tempus AI Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>)
Tempus AI shares rose by 2.17% to close at $69.57. The stock hit an intraday high of $74.2 and a low of $65.37. The 52-week high and low are $91.45 and $22.89, respectively. The&nbsp;shares moved higher&nbsp;ahead of its 2024 fiscal-year <a href="https://www.benzinga.com/general/market-summary/25/02/43920295/palantir-extends-losses-microsoft-slides-whats-driving-markets-monday">fourth-quarter earnings report.</a>
Riot Platforms Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>)
Riot Platforms shares fell by 4.49% to close at $9.99, with an intraday high and low of $10.63 and $9.84, respectively. The 52-week high and low stand at $18.36 and $6.36. The&nbsp;shares climbed&nbsp;after the Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)-mining company reported its <a href="https://www.benzinga.com/news/earnings/25/02/43928216/riot-platforms-shares-climb-after-fy-2024-results-details">fourth-quarter results</a>, which beat the analyst consensus estimate of $372.34 million.
Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>)
Berkshire Hathaway shares rose by 4.11% to close at $498.42. The stock hit an intraday high of $503.96 and a low of $483.24. The 52-week high and low are $503.96 and $395.66, respectively. The <a href="https://in.benzinga.com/analyst-ratings/analyst-color/25/02/43918506/berkshire-hathaway-stock-hits-new-all-time-highs-passes-tesla-analyst-sees-more-upside-ahead">shares hit all-time highs</a> on the heels of the company&#8217;s annual shareholder letter from CEO Warren Buffett. The legendary investor reiterated his belief in U.S. equities in the letter.
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla shares fell by 2.15% to close at $330.53. The stock hit an intraday high of $342.4 and a low of $324.7. The 52-week high and low are $488.54 and $138.8, respectively. The&nbsp;shares traded volatile&nbsp;after the company announced it will deploy <a href="https://www.benzinga.com/news/global/25/02/43922637/tesla-stock-is-trading-volatile-today-whats-driving-the-action">full self-driving features in China</a>.
Image via Shutterstock
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/%E2%80%9CPremarket">with top premarket movers and news</a>&nbsp;by Benzinga.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/exclusives/25/02/43917155/warren-buffett-americas-businesses-usually-find-a-way">Warren Buffett: America&#8217;s Businesses &#8216;Usually Find A Way&#8217;</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

$BTC

PLTR

RIOT

Palantir, Tempus AI, Riot Platforms, Berkshire Hathaway, And Tesla: Why These 5 Stocks Are On Investors' Radars Today (CORRECTED)

Domino&#8217;s Pizza Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) <a href="https://www.benzinga.com/25/02/43909695/dominos-pizza-posts-q4-earnings-below-estimates-stock-falls">missed</a> its fourth-quarter estimates but still delivered about 1% market share gains in the quick service restaurant (QSR) space in the U.S. The management reiterated confidence to "capture additional" market share gains in 2025.
What Happened: CEO Russell Weiner largely attributed the market share gains to the company's focus on value. According to him, their value-driven initiatives like Emergency Pizza, MOREflation, and aggregator partnerships resonated with consumers.
He said "renowned value was key" for its success for the year. "It helped drive market share gains in QSR pizza of about 1% in the U.S., consistent with our average annual share growth since 2015," he added.
Furthermore, talking about the future he said that Domino&#8217;s will deliver U.S. same-store sales growth of "3% or more annually," along with 175 net new stores.
"This would enable Domino&#8217;s to continue to capture additional market share gains in 2025 and beyond," he added.
See Also: <a href="https://www.benzinga.com/25/02/43932776/mark-cuban-slams-fd-up-healthcare-system-blames-insurance-designed-deductibles-for-patient-bankruptcy\">Mark Cuban Calls Deductibles &#8216;The Biggest Problem&#8217; in Healthcare: &#8216;System…Needs To Be Redesigned&#8217;</a>
Why It Matters: The company fell short of the fourth quarter expectations despite expanding global retail sales. Revenue rose 2.9% to $1.44 billion, missing the $1.48 billion estimate. Global retail sales increased 4.4% excluding currency impact, fueled by 364 new stores globally. U.S. same-store sales edged up 0.4%, while international grew 2.7% excluding currency. EPS was $4.89, below the anticipated $4.92.
The company also raised its dividend by 15.2% to $1.74 with a record date of March 14, to be paid on&nbsp;March 28. 
CFO Sandeep Reddy said that the company expects an operating profit growth of approximately 8% excluding the impact of currency next year. "At current exchange rates, we are expecting foreign currency to be a headwind of approximately 1% to 2% on operating income growth," he added.
Price Action: Domino's fell 1.46% on Monday, contrasting with a 1.18% decline in the Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which tracks the Nasdaq 100 index.
DPZ remains higher by 4.76% on a year-to-date basis and 0.73% lower over a year.
<a href="https://www.benzinga.com/quote/DPZ/analyst-ratings">Benzinga tracks 29 analysts</a> with an average price target of $502.97 for the stock, reflecting a &#8220;buy&#8221; rating. Estimates range widely from $402 to $612. Recent ratings from TD Cowen, Stephens &amp; Co., and TD Securities average $466.67, suggesting a potential 2.13% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/DPZ/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="387" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25015318/DPZ-ANR-1024x387.png" alt="" class="wp-image-796781" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25015318/DPZ-ANR-1024x387.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25015318/DPZ-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25015318/DPZ-ANR-768x290.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/25015318/DPZ-ANR.png 1083w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43912631/apple-forced-to-kiss-the-ring-expert-questions-whether-trump-pushed-the-iphone-maker-for-500-billion-investment" target="_blank" rel="noreferrer noopener">Apple ‘Forced To Kiss The Ring'? Expert Questions Whether Trump Pushed The iPhone Maker For $500 Billion Investment</a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Domino's Pizza Sees 1% QSR Market Share Increase Despite Q4 Earnings Miss: 'Consistent With Our Average Annual Share Growth'

Gold prices hit an all-time high Monday as President Donald Trump's <a href="https://www.benzinga.com/news/global/25/02/43926015/trump-confirms-tariffs-on-canada-mexico-will-take-effect-as-planned">tariff threat</a> sent risk-on markets lower, driving demand for the safe haven asset.
What happened: Spot gold rose to $2,956 per ounce early morning before dipping to $2,937.67 as of this writing. Gold futures on the Commodity Exchange also climbed to an intraday high of 2,970.39 before settling at $2.952.
The yellow metal has gained 12.3% year-to-date and roughly 44% over the last 12 months.&nbsp;
Gold's rise contrasted with that of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), often dubbed the "digital gold" by its advocates, as the apex cryptocurrency slid 4.48% in the last 24 hours. Blue-chip stock indexes like the Nasdaq Composite and the S&amp;P 500 also closed <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43930754/bitcoin-ethereum-dogecoin-bleed-amid-trumps-tariff-threat-bybit-mega-breach-analyst-says-mid-bull-reset-not-unprecedented-full-blown-bear-market-not-yet-here">Monday's trading session in the red</a>.
Meanwhile, Pax Gold (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/paxg/usd">PAXG</a>), a cryptocurrency backed by physical gold, was among the market&#8217;s biggest gainers in the last 24 hours.
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/general/entertainment/25/02/43905274/kanye-west-deletes-x-posts-on-potential-meme-coin-unfollows-changpeng-zhao-whats-he-upto">Kanye West Deletes X Posts On Potential Meme Coin, Unfollows Changpeng Zhao — What&#8217;s He Upto?</a>
Why It Matters: Peter Schiff, a renowned gold bug and Bitcoin critic, highlighted how SPDR Gold Trust ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), the world's largest gold exchange-traded fund, has risen 12.42% year-to-date, while Bitcoin-tied ETFs have struggled.&nbsp;
"Instead of 2025 beginning a golden age for Bitcoin, it looks like it will just be a golden age," Schiff threw a jibe.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Gold closed at yet another record high today, above $2,954. <a href="https://twitter.com/search?q=%24GLD&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$GLD</a> also closed at a record high, up 11% YTD. In contrast, ETFs that invest in fool&#39;s gold, aka Bitcoin, are down 3.5% YTD. Instead of 2025 beginning a golden age for Bitcoin, it looks like it will just be a golden age.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1894144793535463434?ref_src=twsrc%5Etfw">February 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
While Bitcoin has certainly struggled this year, it has surpassed gold in terms of annual returns, rising more than 76% vs. the bullion metal's 44% returns.
On a larger time frame, the gulf becomes wider. Bitcoin has gained a whopping 35,807% in the last 10 years, compared to 142% return on gold investment. 
Price Action: At the time of writing, Bitcoin was exchanging hands at $$90,562.19, down 4.48% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Year-to-date, it has lost 3.03% of its value.
Image Via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/financial-advisors/25/02/43903229/advisors-remain-divided-on-crypto-but-sec-approvals-demand-are-shifting-views">Advisors Remain Divided On Crypto, But SEC Approvals, Demand Are Shifting Views</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$PAXG

Bitcoin Is Struggling In 2025 As Gold Clocks New All-Time High But Here Is The Full Picture

Deepwater Management&#8216;s Gene Munster&nbsp;has shared his insights on Apple&#8217;s recent announcement of $500 billion U.S. investments.
What Happened: On Tuesday, Munster took to X to present his analysis of&nbsp;Apple Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)&#8217;s decision to ramp up its annual U.S. expenditures. He believes the tech giant is set to increase its annual U.S. investments by $39 billion, a 45% increase from the 2021 run rate. However, Munster suggests the actual&nbsp;incremental investment is closer to&nbsp;$20 billion annually.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Three takeaways from $AAPL's announcement of investments in the US: 1- The quick math suggests Apple is increasing its annual US expenditures by $39B, up 45% from the run rate outlined in 2021. In reality, the incremental investment is closer to $20B annually. Prior to today's…
&mdash; Gene Munster (@munster_gene) <a href="https://twitter.com/munster_gene/status/1894086801452646772?ref_src=twsrc%5Etfw">February 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also indicated that Apple&#8217;s announcement underscores its realization that an AI-powered future necessitates significant infrastructure investments. He estimates that 15% of the $19 billion incremental spend will be allocated to the hiring of 20,000 new employees, adding roughly $3 billion in annual employee expenses. The remaining 85% is likely to be invested in infrastructure, including expanding data center capacity and chip production for Apple Watches and iPads.
Munster&#8217;s third point underscores Apple&#8217;s strategic approach to bypass tariffs by redirecting those savings into U.S. investments. He estimates that the U.S. accounts for about 35% of Apple&#8217;s total sales, translating to approximately $147 billion in revenue this year. Of that, around $120 billion comes from product sales, which could be affected by the 10% tariffs. Hence, by boosting its domestic investments, Apple could potentially save at least $11 billion per year by avoiding the tariff. Put simply, tariff avoidance covers half of the additional $19 billion in U.S. investment announced.
SEE ALSO: <a href="https://www.benzinga.com/news/global/25/02/43926015/trump-confirms-tariffs-on-canada-mexico-will-take-effect-as-planned">Trump Confirms Tariffs On Canada, Mexico Will Take Effect As Planned</a>
Why It Matters: Apple CEO Tim Cook&#8216;s announcement of this massive investment in the U.S. is being widely perceived as a means to avoid the tariff threat. Tariffs have been a cause of major cause of concern for Apple. Bank of America analyst Analyst Wamsi Mohan had previously stated that iPhone manufacturers will need to increase prices on iPhones, iPads, and other <a href="https://www.benzinga.com/markets/equities/25/02/43839627/apple-may-hike-iphone-prices-by-9-due-to-trumps-tariffs-says-bank-of-america">products by about 9%</a> to offset the impact of tariffs.
Meanwhile, President <a href="https://www.benzinga.com/markets/25/02/43911774/trump-says-apples-500-billion-investment-is-due-to-his-policies-without-which-they-wouldnt-be-investing-ten-cents">Donald Trump stated</a> that the investment was a result of Apple&#8217;s confidence in his administration and policies. 
Apart from Gene Munster, several other analysts have presented their reactions to the iPhone maker&#8217;s $500 billion investment. UBS analyst David Vogt stated that  &#8220;it lacks substance&#8221;, while renowned short-seller James Chanos called it &#8220;unrealistic&#8221; considering Apple&#8217;s current capital base is less than $160 billion. On the other hand, Wedbush&#8217;s Dan Ives said, &#8220;Apple made the smart strategic move with this $500 billion bet on its US buildout.&#8221;
Apple stock closed 0.66% higher at $247.17 on Monday. 
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/25/02/43932533/tesla-starts-rolling-out-fsd-features-in-china">Tesla Starts Rolling Out FSD Features In China A Month After Elon Musk Said EV Giant Faces &#8216;Challenges&#8217; In The Country</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Short Sellers

AAPL

Apple Could Save $11 Billion Annually By Avoiding Tariffs As Tim Cook's Tech Giant Pledges $500 Billion US Investment, Says Top Analyst

Combining 5G Connectivity, Advanced Thermal Imaging, a Slim Design, and Built-to-Endure Toughness

SONM

Sonim XP Pro Thermal 5G Debuts With Military-Grade Durability And Real-Time Thermal Data Streaming

Skanska Selects DXC Technology To Overhaul IT Infrastructure, Boost Efficiency, And Strengthen Security

Teledyne e2v Introduces Lince5M NIR, A High-Speed 5.2MP Sensor For Advanced Industrial And Medical Imaging

"Our Bengaluru expansion represents a critical step in our continued commitment to scaling our global operations and enhancing support for customers worldwide," said Therese Tucker, Founder and co-CEO at BlackLine. "India's deep talent pool and thriving technology ecosystem make it an ideal location to drive innovation, expand our capabilities, and accelerate our global impact to meet growing customer demand."

BlackLine Expands Bengaluru Operations With A 50,000-Square-Foot Office To Drive Global Innovation And Growth

<ul>
<li>New agreement spans packet core, signaling, charging &amp; policy solutions</li>
</ul>

ERIC

Bharti Airtel Partners With Ericsson To Deploy Advanced 5G Core Technology For India's 5G Evolution

51Talk Integrates AI Across Its Platform, Enhancing Personalized Learning And Operational Efficiency

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO Jamie Dimon has voiced criticism over the efficiency of the U.S. government and shown support for the Department of Government Efficiency (DOGE) overseen by Elon Musk.
What Happened: In an interview with <a href="https://www.cnbc.com/2025/02/24/jamie-dimon-us-government-inefficient-touts-elon-musk-doge-effort.html">CNBC</a>&#8216;s Leslie Picker on Monday, Dimon labeled the government as &#8220;inefficient&#8221; and &#8220;not very competent,&#8221; implying that it &#8220;needs a lot of work.&#8221; Although he didn&#8217;t provide a clear-cut response about his stance on DOGE&#8217;s initiatives, his remarks suggested a general endorsement.
Dimon also mentioned the Trump administration&#8217;s initiatives to cut spending and closely examine federal agencies, stating such actions &#8220;need to be done.&#8221; He underscored the need for building appropriate policies and procedures and questioned the benefits derived from government spending.
While Dimon expressed support for DOGE&#8217;s cost-cutting initiatives, he also cautioned against any potential overreach or illegal activities, stating that &#8220;the courts will stop it.&#8221; Nevertheless, Dimon added, "I'm hoping it's quite successful.&#8221;
SEE ALSO: <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43930754/bitcoin-ethereum-dogecoin-bleed-amid-trumps-tariff-threat-bybit-mega-breach-analyst-says-mid-bull-reset-not-unprecedented-full-blown-bear-market-not-yet-here">Bitcoin, Ethereum, Dogecoin Bleed Amid Trump&#8217;s Tariff Threat, Bybit Mega Breach: Analyst Says &#8216;Mid-Bull Reset&#8217; Not Unprecedented, Full-Blown Bear Market Not Yet Here</a>
Why It Matters: Dimon&#8217;s comments come in the backdrop of his recent reconciliation with Elon Musk, CEO of Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>). In late January, Dimon referred to <a href="https://www.benzinga.com/startups/25/01/43339032/jamie-dimon-calls-elon-musk-our-einstein-after-years-of-feuds-weve-hugged-it-out-and-settled-differences-at-tech-summit">Musk as &#8216;Our Einstein&#8217;</a> after years of public feuds and legal disputes. The two reportedly &#8220;hugged it out&#8221; and settled their differences at a tech summit.
The JPMorgan CEO has also expressed his support for President Donald Trump&#8216;s tariff policy, previously. In January, he had told CNBC, that the upcoming tariffs by the Trump administration could be seen in a positive light. "If it's a little inflationary but it's good for national security, so be it. I mean, get over it," Dimon had said. 
Jamie Dimon recently courted controversy after he <a href="https://www.benzinga.com/markets/equities/25/02/43757032/jamie-dimon-goes-off-on-return-to-office-critics-you-dont-have-to-work-at-jpmorgan">condemned remote work</a>, arguing that it hinders creativity and negatively impacts the social and professional development of younger employees. 
Notably, while the JPMorgan CEO has voiced his support for Musk&#8217;s DOGE initiative, several others have criticized the transparency and working of DOGE. A <a href="https://www.benzinga.com/markets/25/02/43906977/elon-musks-doge-savings-of-55-billion-may-be-overstated-wsj-analysis-reveals-the-likely-actual-figure">recent analysis by WSJ</a> also revealed that the savings mentioned on the DOGE website could be overstated. 
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/personal-finance/25/02/43929806/dave-ramsey-says-its-very-difficult-to-trust-someone-in-pajamas-on-a-zoom-call-admits-hes-the-crotchety-old-boss">Dave Ramsey Says &#8216;It&#8217;s Very Difficult To Trust Someone In Pajamas On A Zoom Call&#8217;—Admits He&#8217;s &#8216;The Crotchety Old Boss&#8217;</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Jamie Dimon Slams 'Inefficient' US Government, Backs Elon Musk's DOGE Initiative

Press Releases

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia

Legal

NewAmsterdam Pharma Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

Financing

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

Health Care

NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities

Comments

NewAmsterdam Pharma

NewAmsterdam Pharma (NAMS) Options

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL